Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Personalized Genetic Risk Profile: A New Tool to Guide Prevention of Serious Mental Illness

Project description

A genetic blueprint for mental illness risk

Serious mental illness (SMI) has devastating effects, but preventing it hinges on early diagnosis. This involves identifying individuals at risk before symptoms fully emerge. Current clinical methods are suboptimal, relying only on basic characteristics and often ignoring the risk for non-psychotic SMI disorders such as major depression and bipolar disorder. The ERC-funded PersonalRiskProfile project aims to develop a personalised genetic risk profile (PGRP) software. It will be the first of its kind. Using advanced genetic techniques, it will compute an individual’s risk for multiple SMI disorders. The team will optimise prediction by incorporating subtle polygenic risk scores and rare genetic variants. The PGRP will be validated in clinical cohorts and presented via an intuitive online dashboard.

Objective

Serious mental illness (SMI) has devastating effects. The key clinical challenge is to identify individuals at increased risk for SMI for personalized prevention. However, the specialized clinical teams aiming to identify at-risk individuals face major challenges: risk assessment is suboptimal as only clinical characteristics are considered, and only psychosis is considered ignoring risk for SMI disorders without psychosis.

Genetics has great potential to significantly improve identification of at-risk individuals. However, the major current problem preventing clinical implementation is that no appropriate method exists to accurately assess genetic risk of multiple SMI disorders.

In this ambitious PersonalRiskProfile-project, my team and I will develop this much-needed method and software: the personalized genetic risk profile (PGRP)-method. PGRP will use advanced genetic techniques to simultaneously compute the risk for multiple SMI disorders that regularly but not always include psychosis: schizophrenia, bipolar disorder and major depressive disorder. Specifically, we aim to Optimize Prediction & Generalize to Diverse Ancestries (Aim 1), by including polygenic risk scores for SMI-disorders and auxiliary helper-traits, including rare genetic variants, and accounting for time-since-risk-assessment effects and family information; and to Validate & Prepare for Implementation (Aim 2), by validating PGRP in clinical cohorts, determining the best strategy to integrate PGRP with clinical risk assessment, investigating the stakeholders’ perspective, and developing an Online Dashboard to intuitively present PGRP-results.

This ambitious interdisciplinary project provides a key step towards personalized prevention using genetics. I am uniquely qualified to lead, having established myself as international expert in statistical genetics through development of high-impact innovative methods and prestigious fellowships, combined with my clinical expertise as psychiatrist.

Fields of science (EuroSciVoc)

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC - HORIZON ERC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2025-STG

See all projects funded under this call

Host institution

STICHTING AMSTERDAM UMC
Net EU contribution
€ 1 499 891,00
Total cost
€ 1 499 891,25

Beneficiaries (1)